Concord Medical Services Stock Probability Of Bankruptcy

CCM Stock

USD 0.63 0.05 8.62%

Concord Medical's odds of distress is over 50% at the moment. It has a moderate probability of going through some financial straits in the next 2 years. Concord Medical's Odds of distress is determined by interpolating and adjusting Concord Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Concord balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

As of the 7th of May 2024, Enterprise Value is likely to grow to about 3.8 B, while Market Cap is likely to drop about 324 M.

Concord Medical Services Company odds of distress Analysis

Concord Medical's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Concord Medical Probability Of Bankruptcy

Over 56%

Most of Concord Medical's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Concord Medical probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Concord Medical odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Concord Medical Services financial health.

Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.94)

Revenue Per Share

12.302

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.05)

Return On Equity

(0.28)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Concord Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.53	0.76	0.55	0.82	0.78	0.75	0.74	0.7	0.77	-0.7	0.44	0.21	-0.09	0.31	-0.31	-0.63	-0.75	0.3	0.32	-0.3	0.72	0.67	0.12	-0.75	-0.35	-0.19
Total Stockholder Equity	-0.53		-0.9	-0.69	-0.81	-0.59	-0.03	-0.92	-0.69	-0.85	0.95	-0.4	0.42	0.59	-0.22	0.78	0.64	0.89	-0.27	-0.38	0.14	-0.92	-0.67	-0.05	0.9	0.71	0.6
Long Term Debt	0.76	-0.9		0.66	0.88	0.64	0.32	0.98	0.83	0.92	-0.94	0.4	-0.19	-0.5	0.17	-0.66	-0.72	-0.94	0.41	0.33	-0.32	0.98	0.74	0.0	-0.9	-0.6	-0.46
Good Will	0.55	-0.69	0.66		0.69	0.35	0.32	0.75	0.52	0.78	-0.83	0.83	-0.34	-0.43	0.43	-0.33	-0.21	-0.66	0.07	0.24	0.26	0.71	0.25	0.04	-0.73	-0.8	-0.71
Total Liab	0.82	-0.81	0.88	0.69		0.74	0.54	0.91	0.61	0.96	-0.9	0.53	-0.1	-0.19	0.58	-0.59	-0.76	-0.85	0.39	0.41	-0.27	0.9	0.81	0.04	-0.84	-0.69	-0.62
Intangible Assets	0.78	-0.59	0.64	0.35	0.74		0.47	0.63	0.51	0.6	-0.61	0.17	0.12	-0.07	0.26	-0.5	-0.85	-0.63	0.31	0.43	-0.3	0.61	0.85	0.29	-0.73	-0.22	-0.14
Common Stock	0.75	-0.03	0.32	0.32	0.54	0.47		0.35	0.19	0.46	-0.29	0.23	0.32	0.28	0.46	0.2	-0.38	-0.35	0.19	0.11	-0.27	0.33	0.42	0.02	-0.31	-0.22	-0.17
Property Plant Equipment	0.74	-0.92	0.98	0.75	0.91	0.63	0.35		0.74	0.95	-0.97	0.45	-0.33	-0.51	0.28	-0.66	-0.7	-0.94	0.37	0.32	-0.24	1.0	0.73	0.02	-0.94	-0.73	-0.61
Current Deferred Revenue	0.7	-0.69	0.83	0.52	0.61	0.51	0.19	0.74		0.66	-0.74	0.37	0.08	-0.37	-0.12	-0.53	-0.48	-0.76	0.17	0.45	-0.15	0.75	0.49	0.18	-0.73	-0.25	-0.1
Net Debt	0.77	-0.85	0.92	0.78	0.96	0.6	0.46	0.95	0.66		-0.94	0.6	-0.2	-0.37	0.51	-0.61	-0.66	-0.87	0.39	0.33	-0.19	0.94	0.71	-0.1	-0.83	-0.78	-0.64
Retained Earnings	-0.7	0.95	-0.94	-0.83	-0.9	-0.61	-0.29	-0.97	-0.74	-0.94		-0.55	0.33	0.51	-0.33	0.64	0.62	0.92	-0.29	-0.38	0.11	-0.96	-0.66	-0.04	0.93	0.77	0.65
Accounts Payable	0.44	-0.4	0.4	0.83	0.53	0.17	0.23	0.45	0.37	0.6	-0.55		-0.03	-0.11	0.56	-0.19	0.03	-0.37	0.01	0.19	0.39	0.42	0.01	-0.06	-0.41	-0.6	-0.52
Net Receivables	0.21	0.42	-0.19	-0.34	-0.1	0.12	0.32	-0.33	0.08	-0.2	0.33	-0.03		0.63	-0.05	0.38	0.02	0.18	-0.12	0.12	-0.24	-0.32	-0.06	-0.03	0.31	0.58	0.61
Total Current Assets	-0.09	0.59	-0.5	-0.43	-0.19	-0.07	0.28	-0.51	-0.37	-0.37	0.51	-0.11	0.63		0.34	0.55	0.23	0.41	-0.11	-0.1	-0.21	-0.5	-0.19	0.25	0.49	0.41	0.22
Short Term Debt	0.31	-0.22	0.17	0.43	0.58	0.26	0.46	0.28	-0.12	0.51	-0.33	0.56	-0.05	0.34		-0.12	-0.22	-0.19	0.2	0.18	0.1	0.27	0.31	-0.12	-0.17	-0.63	-0.65
Short Term Investments	-0.31	0.78	-0.66	-0.33	-0.59	-0.5	0.2	-0.66	-0.53	-0.61	0.64	-0.19	0.38	0.55	-0.12		0.66	0.57	-0.33	-0.5	0.03	-0.66	-0.65	0.05	0.61	0.42	0.34
Treasury Stock	-0.63	0.64	-0.72	-0.21	-0.76	-0.85	-0.38	-0.7	-0.48	-0.66	0.62	0.03	0.02	0.23	-0.22	0.66		0.64	-0.43	-0.48	0.39	-0.7	-0.98	-0.08	0.66	0.27	0.23
Net Tangible Assets	-0.75	0.89	-0.94	-0.66	-0.85	-0.63	-0.35	-0.94	-0.76	-0.87	0.92	-0.37	0.18	0.41	-0.19	0.57	0.64		-0.2	-0.3	0.38	-0.94	-0.67	-0.05	0.95	0.62	0.48
Deferred Long Term Liab	0.3	-0.27	0.41	0.07	0.39	0.31	0.19	0.37	0.17	0.39	-0.29	0.01	-0.12	-0.11	0.2	-0.33	-0.43	-0.2		-0.17	-0.39	0.4	0.53	-0.19	-0.19	-0.24	-0.11
Long Term Investments	0.32	-0.38	0.33	0.24	0.41	0.43	0.11	0.32	0.45	0.33	-0.38	0.19	0.12	-0.1	0.18	-0.5	-0.48	-0.3	-0.17		0.3	0.32	0.43	0.01	-0.33	-0.14	-0.13
Short Long Term Debt	-0.3	0.14	-0.32	0.26	-0.27	-0.3	-0.27	-0.24	-0.15	-0.19	0.11	0.39	-0.24	-0.21	0.1	0.03	0.39	0.38	-0.39	0.3		-0.27	-0.41	-0.18	0.22	-0.15	-0.09
Long Term Debt Total	0.72	-0.92	0.98	0.71	0.9	0.61	0.33	1.0	0.75	0.94	-0.96	0.42	-0.32	-0.5	0.27	-0.66	-0.7	-0.94	0.4	0.32	-0.27		0.74	0.02	-0.92	-0.72	-0.6
Capital Surpluse	0.67	-0.67	0.74	0.25	0.81	0.85	0.42	0.73	0.49	0.71	-0.66	0.01	-0.06	-0.19	0.31	-0.65	-0.98	-0.67	0.53	0.43	-0.41	0.74		0.05	-0.67	-0.37	-0.28
Cash And Equivalents	0.12	-0.05	0.0	0.04	0.04	0.29	0.02	0.02	0.18	-0.1	-0.04	-0.06	-0.03	0.25	-0.12	0.05	-0.08	-0.05	-0.19	0.01	-0.18	0.02	0.05		-0.19	0.26	-0.08
Net Invested Capital	-0.75	0.9	-0.9	-0.73	-0.84	-0.73	-0.31	-0.94	-0.73	-0.83	0.93	-0.41	0.31	0.49	-0.17	0.61	0.66	0.95	-0.19	-0.33	0.22	-0.92	-0.67	-0.19		0.63	0.52
Net Working Capital	-0.35	0.71	-0.6	-0.8	-0.69	-0.22	-0.22	-0.73	-0.25	-0.78	0.77	-0.6	0.58	0.41	-0.63	0.42	0.27	0.62	-0.24	-0.14	-0.15	-0.72	-0.37	0.26	0.63		0.87
Capital Stock	-0.19	0.6	-0.46	-0.71	-0.62	-0.14	-0.17	-0.61	-0.1	-0.64	0.65	-0.52	0.61	0.22	-0.65	0.34	0.23	0.48	-0.11	-0.13	-0.09	-0.6	-0.28	-0.08	0.52	0.87

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Concord Medical

Based on the latest financial disclosure, Concord Medical Services has a Probability Of Bankruptcy of 56%. This is 29.36% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 40.6% lower than that of the firm.

Concord Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.

Concord Medical is currently under evaluation in probability of bankruptcy category among related companies.

Concord Medical Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	(0.0819)	(0.0757)	(0.0839)	(0.13)	(0.0492)	(0.0516)
Asset Turnover	0.0462	0.0418	0.078	0.0786	0.0888	0.13
Gross Profit Margin	0.1	(0.0798)	0.0587	(0.12)	(0.32)	(0.14)
Net Debt	533.4M	1.8B	2.0B	3.1B	3.2B	3.4B
Total Current Liabilities	870.3M	627.5M	512.1M	1.1B	2.0B	2.0B
Non Current Liabilities Total	1.4B	1.8B	2.4B	2.9B	2.4B	1.3B
Total Assets	4.6B	4.3B	5.3B	6.0B	6.1B	4.0B
Total Current Assets	1.2B	282.5M	676.0M	759.8M	617.2M	741.5M
Total Cash From Operating Activities	(38.6M)	(195.3M)	(229.8M)	(216.7M)	(276.5M)	(262.6M)

Concord Fundamentals

	Return On Equity	-0.28
	Return On Asset	-0.048
	Profit Margin	(0.55) %
	Operating Margin	(0.98) %
	Current Valuation	7.19 B
	Shares Outstanding	43.42 M
	Shares Owned By Insiders	17.99 %
	Shares Owned By Institutions	0.10 %
	Number Of Shares Shorted	6.93 K
	Price To Earning	(3.90) X
	Price To Book	3.00 X
	Price To Sales	0.04 X
	Revenue	537.4 M
	Gross Profit	(152.41 M)
	EBITDA	(313.75 M)
	Net Income	(531.02 M)
	Cash And Equivalents	157.39 M
	Cash Per Share	1.72 X
	Total Debt	3.3 B
	Debt To Equity	1.25 %
	Current Ratio	0.71 X
	Book Value Per Share	(48.87) X
	Cash Flow From Operations	(276.47 M)
	Short Ratio	0.37 X
	Earnings Per Share	(0.94) X
	Target Price	1.2
	Number Of Employees	727
	Beta	-0.17
	Market Capitalization	27.35 M
	Total Asset	6.05 B
	Retained Earnings	(4.06 B)
	Working Capital	(1.33 B)
	Current Asset	1.51 B
	Current Liabilities	1.51 B
	Net Asset	6.05 B

About Concord Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets

Earnings Share

(0.94)

Revenue Per Share

12.302

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.05)

Return On Equity

(0.28)

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Medical Services Stock Probability Of Bankruptcy

Concord Medical Services Company odds of distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Concord Medical Probability Of Bankruptcy

Concord Probability Of Bankruptcy Driver Correlations

Concord Probability Of Bankruptcy Peer Comparison

Concord Medical Main Bankruptcy Drivers

Concord Fundamentals

About Concord Medical Fundamental Analysis

Complementary Tools for Concord Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY